VirnetX Holding Corporation  

(Public, NYSEMKT:VHC)   Watch this stock  
Find more results for NYSEAMEX:VHC
14.50
0.00 (0.00%)
Apr 22 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range     -
52 week 12.10 - 26.25
Open     -
Vol / Avg. 0.00/642,520.00
Mkt cap 746.64M
P/E     -
Div/yield     -
EPS -0.54
Shares 51.49M
Beta 2.25
Inst. own 30%
May 22, 2014
VirnetX 2014 Annual Shareholders Meeting - 12:30PM EDT - Add to calendar
May 5, 2014
Q1 2014 VirnetX Holding Corporation Earnings Release (Estimated) Add to calendar
Mar 3, 2014
Q4 2013 VirnetX Holding Corporation Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin -2641.26% -1256.62%
Operating margin -2568.53% -1301.18%
EBITD margin - -1299.55%
Return on average assets -71.96% -54.83%
Return on average equity -82.62% -62.77%
Employees 15 -
CDP Score - -

Address

SUITE 206, 308 DORLA COURT
ZEPHYR COVE, NV 89448
United States - Map
+1-831-4388200 (Phone)
+1-775-5807527 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

VirnetX Holding Corporation, is engaged in the business of commercializing a portfolio of patents. The Company seeks to license its technology, including GABRIEL Connection Technology, to various original equipment manufacturers, or OEMs, that use its technologies in the development and manufacturing of their own products within the IP-telephony, mobility, fixed-mobile convergence and unified communications markets. As of December 31, 2012, the Company owned 20 issued U.S. and 32 issued foreign patents, in addition to several pending U.S. and foreign patent applications. On January 29, 2013, the Company entered into a License Agreement with Siemens Enterprise Communications GmbH & Co. KG, and Siemens Enterprise Communications Inc.

Officers and directors

Kendall Larsen Chairman of the Board, President, Chief Executive Officer
Age: 56
Bio & Compensation  - Reuters
Richard H. Nance Chief Financial Officer
Age: 64
Bio & Compensation  - Reuters
Robert D. Short III, Ph.D. Chief Technology Officer, Chief Scientist, Director
Age: 61
Bio & Compensation  - Reuters
Michael F. Angelo Independent Director
Age: 53
Bio & Compensation  - Reuters
Thomas M. O'Brien Independent Director
Age: 61
Bio & Compensation  - Reuters
Scott C. Taylor Independent Director
Age: 49
Bio & Compensation  - Reuters